Privia Health Group Inc. Crosses Above 200-Day Moving Average of $22.29
ByAinvest
Friday, Aug 29, 2025 12:23 pm ET1min read
PRVA--
The stock's performance aligns with Privia Health Group's recent achievements in the Medicare shared savings program. The company reported that its Accountable Care Organizations (ACOs) achieved shared savings of $233.1 million through the Medicare shared savings program for the 2024 performance year, a 32% increase compared to 2023 [1]. This positive result has led to an upward revision in Privia's Adjusted EBITDA guidance for the full year of 2025, now projected to be between $113 million and $116 million [1].
The bullish trend is further supported by the stock's crossing above its 200-day moving average. This technical indicator often signals a change in the stock's momentum, suggesting that the price may continue to rise in the short to medium term. Additionally, the stock's 52-week high of $26.0899 indicates strong investor confidence in the company's future prospects.
Investors should closely monitor Privia Health Group's earnings call for the second quarter of 2025, scheduled to be held on July 2, 2025, for further insights into the company's financial performance and future outlook.
References:
[1] https://seekingalpha.com/news/4490529-privia-healths-acos-report-32-rise-in-medicare-savings
[2] https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-prva
Privia Health Group Inc (PRVA) shares crossed above their 200-day moving average of $22.29, reaching a high of $23.48 per share and trading up 5.8% on the day. This indicates a bullish trend for the company, with a 52-week range of $16.47 to $26.0899.
Privia Health Group Inc (PRVA) shares experienced a significant uptick on Friday, crossing above their 200-day moving average of $22.29 and reaching a high of $23.48 per share. This move, which saw the stock trading up 5.8% on the day, indicates a bullish trend for the company. The stock's 52-week range is now between $16.47 and $26.0899, reflecting a strong performance over the past year.The stock's performance aligns with Privia Health Group's recent achievements in the Medicare shared savings program. The company reported that its Accountable Care Organizations (ACOs) achieved shared savings of $233.1 million through the Medicare shared savings program for the 2024 performance year, a 32% increase compared to 2023 [1]. This positive result has led to an upward revision in Privia's Adjusted EBITDA guidance for the full year of 2025, now projected to be between $113 million and $116 million [1].
The bullish trend is further supported by the stock's crossing above its 200-day moving average. This technical indicator often signals a change in the stock's momentum, suggesting that the price may continue to rise in the short to medium term. Additionally, the stock's 52-week high of $26.0899 indicates strong investor confidence in the company's future prospects.
Investors should closely monitor Privia Health Group's earnings call for the second quarter of 2025, scheduled to be held on July 2, 2025, for further insights into the company's financial performance and future outlook.
References:
[1] https://seekingalpha.com/news/4490529-privia-healths-acos-report-32-rise-in-medicare-savings
[2] https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-prva

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet